InCites is a customized online citation-based research evaluation tool that enables you to visualize research performance, benchmark performance relative to peers, develop collaborative partnerships and analyze research trends using modern bibliometric tools.
Based on the literature database Web of Science, InCites enables the visualisation and comparison of publication output and impact of individual institutions with regard to various parameters.
For example, it is possible to analyse how often an institution publishes in cooperation with industrial partners or which are the institutions with which your scientists co-publish most often. The newly launched Research Horizon Navigator™, a new discovery module within InCites Benchmarking & Analytics is designed to empower academics, funding agencies, research strategists and publishers to identify new research areas that point to where future breakthroughs are likely to occur.
A new interdisciplinarity indicator unveils how topics form, grow, branch out and merge across the humanities, sciences and social sciences to form distinctive new fields.
Please attend this webinar to explore the search interface and research different possibilities with the platform.
The topics covered will include:
An overview of InCites Entities
Introduction to InCites Metrics and recommended use
Responsible use of InCites Metrics
Tracking Institutional Performance
Citations from Patents-Tracking the commercial potential of research
Benchmarking Performance
Understanding funding landscape
Identifying collaboration trends
Journal Usage Trends
Introduction to Research Horizon Navigator
Reporting on InCites
Register below and we'll send the details.
Speaker
Dr. Subhasree Nag
Senior Business Solution Consultant
Clarivate
Dr. Subhasree Nag is a senior business solution consultant for the scholarly research and life sciences division at Clarivate.
She completed her PhD from Texas Tech University Health Sciences Center, USA and her post-doctoral training from Pacific Northwest National Laboratory, USA.
A pharmacologist and toxicologist by training, she has more than 8 years of research experience in anticancer drug discovery and pharmacokinetics areas with 25 peer reviewed publications and more than 1500 citations.
At Clarivate, she is involved in promoting Clarivate's scholarly research, drug discovery and intellectual property (IP) solutions, conducting author and research capacity workshops, bespoke consulting projects, etc.
She was a co-author on the UGC-Good Academic Research Practices guidance document released in 2020. She also writes for the Clarivate pharma industry magazine, Bioworld, where she contributes to articles related to early-stage discovery and preclinical studies.
